Cargando…
Molecular Mechanisms and Therapeutics for SBMA/Kennedy’s Disease
Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disease caused by a polyglutamine (polyQ) expansion in the androgen receptor (AR). Despite the fact that the monogenic cause of SBMA has been known for nearly 3 decades, there is no effective treatment for this disease, underscoring the co...
Autores principales: | Arnold, Frederick J., Merry, Diane E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985201/ https://www.ncbi.nlm.nih.gov/pubmed/31686397 http://dx.doi.org/10.1007/s13311-019-00790-9 |
Ejemplares similares
-
The French national protocol for Kennedy’s disease (SBMA): consensus diagnostic and management recommendations
por: Pradat, Pierre-François, et al.
Publicado: (2020) -
Molecular mechanism of SbmA, a promiscuous transporter exploited by antimicrobial peptides
por: Ghilarov, Dmitry, et al.
Publicado: (2021) -
Increased SIRT3 combined with PARP inhibition rescues motor function of SBMA mice
por: Garcia Castro, David R., et al.
Publicado: (2023) -
Macroautophagy Is Regulated by the UPR–Mediator CHOP and Accentuates the Phenotype of SBMA Mice
por: Yu, Zhigang, et al.
Publicado: (2011) -
Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity
por: Klickovic, Uros, et al.
Publicado: (2019)